Growth Hormone Deficiency, H2 Market Research Report 2015

1
Growth Hormone Deficiency Pipeline Review, H2 2015
No. Pages 111
Published on October - 2015
2
.
Report Overview
About Growth Hormone Deficiency Pipeline Review,
H2 2015 Research Beam added report on Growth
Hormone Deficiency Pipeline Review, H2 2015.
Summary Global Markets Directs, Growth Hormone
Deficiency Pipeline Review, H2 2015, provides an
overview of the Growth Hormone Deficiency s
therapeutic pipeline. This report provides
comprehensive information on the therapeutic
development for Growth Hormone Deficiency,
complete with comparative analysis at various
stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of
administration (RoA) and molecule type, along
with latest updates, and featured news and press
releases. It also reviews key players involved in
the therapeutic development for Growth Hormone
Deficiency and special features on late-stage and
discontinued projects. Get Full Details On
http//www.researchbeam.com/growth-hormone-deficie
ncy-pipeline-review-h2-2015-market
3
.
Report Overview
Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes
periodic updation following a stringent set of
processes that ensures that all the profiles are
updated with the latest set of information.
Additionally, processes including live news
deals tracking, browser based alert-box and
clinical trials registries tracking ensure that
the most recent developments are captured on a
real time basis. The report enhances decision
making capabilities and help to create effective
counter strategies to gain competitive advantage.
It strengthens RD pipelines by identifying new
targets and MOAs to produce first-in-class and
best-in-class products. Note Certain sections
in the report may be removed or altered based on
the availability and relevance of data for the
indicated disease.  
4
.
Report Overview
Scope The report provides a snapshot of the
global therapeutic landscape of Growth Hormone
Deficiency The report reviews key pipeline
products under drug profile section which
includes, product description, MoA and RD brief,
licensing and collaboration details other
developmental activities The report reviews key
players involved in the therapeutics development
for Growth Hormone Deficiency and enlists all
their major and minor projects The report
summarizes all the dormant and discontinued
pipeline projects A review of the Growth Hormone
Deficiency products under development by
companies and universities/research institutes
based on information derived from company and
industry-specific sources Pipeline products
coverage based on various stages of development
ranging from pre-registration till discovery and
undisclosed stages. A detailed assessment of
monotherapy and combination therapy pipeline
projects Coverage of the Growth Hormone
Deficiency pipeline on the basis of target, MoA,
route of administration and molecule type  
5
Report Overview
Reasons to buy  Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage Develop strategic initiatives by
understanding the focus areas of leading
companies Identify and understand important and
diverse types of therapeutics under development
for Growth Hormone Deficiency Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline Devise
corrective measures for pipeline projects by
understanding Growth Hormone Deficiency pipeline
depth and focus of Indication therapeutics Develop
and design in-licensing and out-licensing
strategies by identifying prospective partners
with the most attractive projects to enhance and
expand business potential and Scope Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline  
6
Table Of Contents
List of Tables 6List of Figures 7Introduction
8Global Markets Direct Report Coverage 8Growth
Hormone Deficiency Overview 9Therapeutics
Development 10Pipeline Products for Growth
Hormone Deficiency - Overview 10Pipeline
Products for Growth Hormone Deficiency -
Comparative Analysis 11Growth Hormone Deficiency
- Therapeutics under Development by Companies
12Growth Hormone Deficiency - Pipeline Products
Glance 15Late Stage Products 15Clinical Stage
Products 16Early Stage Products 17Unknown Stage
Products 18
7
Table Of Contents
Growth Hormone Deficiency - Products under
Development by Companies 19Growth Hormone
Deficiency - Companies Involved in Therapeutics
Development 20Aeterna Zentaris Inc. 20Aileron
Therapeutics, Inc. 21Ascendis Pharma A/S
22Biogenomics Limited 23Bolder Biotechnology,
Inc. 24Braasch Biotech LLC 25Carlina
Technologies SAS 26Critical Pharmaceuticals
Limited 27Delpor, Inc. 28Flamel Technologies
S.A. 29Genexine, Inc. 30HanAll Biopharma Co.,
Ltd. 31
8
Table Of Contents
Hanmi Pharmaceuticals, Co. Ltd. 32Inbiopro
Solutions Pvt. Ltd. 33JCR Pharmaceuticals Co.,
Ltd. 34LG Life Sciences Limited 35OPKO Health,
Inc. 36Pfenex Inc. 37Prometheon Pharma, LLC
38Teva Pharmaceutical Industries Limited
39Versartis, Inc. 40XL-protein GmbH 41Growth
Hormone Deficiency - Therapeutics Assessment
42Enquiry about this report _at_ http//www.research
beam.com/growth-hormone-deficiency-pipeline-review
-h2-2015-market/enquire-about-report
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/growth-hormone-deficie
ncy-pipeline-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] E-MAIL
sales_at_researchbeam.com